BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chew-Harris JS, Florkowski CM, George PM, Endre ZH. Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients. Asia Pac J Clin Oncol 2015;11:142-51. [PMID: 25471594 DOI: 10.1111/ajco.12312] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Berton M, Bettonte S, Stader F, Battegay M, Marzolini C. Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models. Clin Pharmacokinet 2022. [PMID: 35699913 DOI: 10.1007/s40262-022-01132-3] [Reference Citation Analysis]
2 Imoto Y, Naito T, Miyadera Y, Ono T, Kawakami J. Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder. Eur J Clin Pharmacol 2021;77:369-79. [PMID: 33033881 DOI: 10.1007/s00228-020-03010-y] [Reference Citation Analysis]
3 Uekuzu Y, Higashiguchi T, Futamura A, Chihara T, Usui M. Influence of muscle mass on the estimation of glomerular filtration rate in Japanese terminal cancer patients. Clin Exp Nephrol 2020;24:876-84. [PMID: 32621075 DOI: 10.1007/s10157-020-01906-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Teaford HR, Barreto JN, Vollmer KJ, Rule AD, Barreto EF. Cystatin C: A Primer for Pharmacists. Pharmacy (Basel) 2020;8:E35. [PMID: 32182861 DOI: 10.3390/pharmacy8010035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
5 He L, Li J, Zhan J, Yi F, Fan X, Wei Y, Zhang W. The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis. Cancer Chemother Pharmacol 2019;83:561-71. [PMID: 30610366 DOI: 10.1007/s00280-018-3762-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
6 Kwon WS, Kim TS, Nahm CH, Moon Y, Kim JJ. Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden. Oncol Lett 2018;16:5583-90. [PMID: 30344712 DOI: 10.3892/ol.2018.9380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Delanaye P, Guerber F, Scheen A, Ellam T, Bouquegneau A, Guergour D, Mariat C, Pottel H. Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies. Clin Pharmacokinet 2017;56:193-205. [PMID: 27417226 DOI: 10.1007/s40262-016-0434-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
8 Tong Y, Liu X, Guan M, Wang M, Zhang L, Dong D, Niu R, Zhang F, Zhou Y. Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients. Med Sci Monit 2017;23:2949-60. [PMID: 28623247 DOI: 10.12659/msm.902138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Jones M, Denieffe S, Griffin C, Tinago W, Fitzgibbon MC. Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients. Pract Lab Med 2017;8:95-104. [PMID: 28856234 DOI: 10.1016/j.plabm.2017.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Cavalcanti E, Barchiesi V, Cerasuolo D, Di Paola F, Cantile M, Cecere SC, Pignata S, Morabito A, Costanzo R, Di Maio M, Perrone F. Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy. Anal Cell Pathol (Amst) 2016;2016:4918325. [PMID: 28078200 DOI: 10.1155/2016/4918325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Chew-Harris JS, Chin PK, Florkowski CM, George P, Endre Z. Removal of body surface area normalisation improves raw-measured glomerular filtration rate estimation by the Chronic Kidney Disease Epidemiology Collaboration equation and drug dosing in the obese. Intern Med J 2015;45:766-73. [PMID: 25904102 DOI: 10.1111/imj.12791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
12 Delanaye P, Flamant M, Cavalier É, Guerber F, Vallotton T, Moranne O, Pottel H, Boffa JJ, Mariat C. [Dosing adjustment and renal function: Which equation(s)?]. Nephrol Ther 2016;12:18-31. [PMID: 26602880 DOI: 10.1016/j.nephro.2015.07.472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
13 Shibata K, Yasuda Y, Kobayashi R, Ando Y, Shimokata T, Kamiya H, Hayashi M, Maruyama S, Matsuo S, Nakao M, Tsuchiya T, Teramachi H. Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1. Clin Exp Nephrol 2015;19:1107-13. [PMID: 25894220 DOI: 10.1007/s10157-015-1115-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]